Skip to main content
Top
Published in: Journal of Neurology 6/2017

Open Access 01-06-2017 | Original Communication

Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy

Authors: Sandra Moreira, Libby Wood, Debbie Smith, Chiara Marini-Bettolo, Michela Guglieri, Grace McMacken, Geraldine Bailey, Anna Mayhew, Robert Muni-Lofra, Gail Eglon, Maggie Williams, Volker Straub, Hanns Lochmüller, Teresinha Evangelista

Published in: Journal of Neurology | Issue 6/2017

Login to get access

Abstract

Understand the occurrence and predictors of respiratory impairment in FSHD. Data from 100 FSHD patients was collected regarding demographics, genetics, respiratory status and pulmonary function tests, clinical manifestations and Clinical Severity Scale (CSS) scores. Patients were assigned to two severity groups using CSS: mild (scores <3.5) and moderate/severely affected (scores ≥3.5). Forced Vital Capacity (FVC) was classified as severely impaired if less than 50% of the predicted. Statistical analysis was performed using IBM SPSS Statistics 23, tests were two-tailed and the level of significance set at 5%. Spirometry was available for 94 patients; 41.5% had abnormal results with a restrictive pattern in 38.3% patients. There was a correlation between FVC; CSS score and D4Z4 fragment length with a higher probability of severe respiratory involvement in the early onset group, moderate/severe disease and D4Z4 fragments <18 kb. Patients with severe respiratory involvement showed a high prevalence of sleep-disordered breathing. FVC decline over time was indicative of three progression groups. Respiratory involvement for both ambulant and non-ambulant patients with FSHD is more frequent and severe than previously suggested. Sleep-disordered breathing is frequent and negatively influences the respiratory status. Annual screening of the respiratory status with spirometry and clinical assessment is thus warranted in FSHD patients, even while ambulant.
Appendix
Available only for authorised users
Literature
1.
go back to reference Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain J Neurol 132(Pt 11):3175–3186CrossRef Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain J Neurol 132(Pt 11):3175–3186CrossRef
2.
go back to reference Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R et al (2014) Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology 43(3–4):259–268CrossRefPubMed Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R et al (2014) Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology 43(3–4):259–268CrossRefPubMed
3.
go back to reference Sacconi S, Salviati L, Desnuelle C (2015) Facioscapulohumeral muscular dystrophy. Biochem Biophys Acta 1852(4):607–614PubMed Sacconi S, Salviati L, Desnuelle C (2015) Facioscapulohumeral muscular dystrophy. Biochem Biophys Acta 1852(4):607–614PubMed
4.
go back to reference Tawil R, Kissel JT, Heatwole C, Pandya S, Gronseth G, Benatar M (2015) Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular and Electrodiagnostic Medicine. Neurology 85(4):357–364CrossRefPubMedPubMedCentral Tawil R, Kissel JT, Heatwole C, Pandya S, Gronseth G, Benatar M (2015) Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular and Electrodiagnostic Medicine. Neurology 85(4):357–364CrossRefPubMedPubMedCentral
5.
go back to reference Evangelista T, Wood L, Fernandez-Torron R, Williams M, Smith D, Lunt P et al (2016) Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry. J Neurol 263(7):1401–1408CrossRefPubMedPubMedCentral Evangelista T, Wood L, Fernandez-Torron R, Williams M, Smith D, Lunt P et al (2016) Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry. J Neurol 263(7):1401–1408CrossRefPubMedPubMedCentral
6.
go back to reference Chen TH, Lai YH, Lee PL, Hsu JH, Goto K, Hayashi YK et al (2013) Infantile facioscapulohumeral muscular dystrophy revisited: expansion of clinical phenotypes in patients with a very short EcoRI fragment. Neuromuscul Dis NMD 23(4):298–305CrossRef Chen TH, Lai YH, Lee PL, Hsu JH, Goto K, Hayashi YK et al (2013) Infantile facioscapulohumeral muscular dystrophy revisited: expansion of clinical phenotypes in patients with a very short EcoRI fragment. Neuromuscul Dis NMD 23(4):298–305CrossRef
7.
go back to reference Dorobek M, van der Maarel SM, Lemmers RJ, Ryniewicz B, Kabzinska D, Frants RR et al (2015) Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features. J Child Neurol 30(5):580–587CrossRefPubMed Dorobek M, van der Maarel SM, Lemmers RJ, Ryniewicz B, Kabzinska D, Frants RR et al (2015) Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features. J Child Neurol 30(5):580–587CrossRefPubMed
8.
go back to reference Larsen M, Rost S, El Hajj N, Ferbert A, Deschauer M, Walter MC et al (2015) Diagnostic approach for FSHD revisited: sMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Human Genet EJHG 23(6):808–816CrossRefPubMed Larsen M, Rost S, El Hajj N, Ferbert A, Deschauer M, Walter MC et al (2015) Diagnostic approach for FSHD revisited: sMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Human Genet EJHG 23(6):808–816CrossRefPubMed
9.
go back to reference Lemmers RJ, O’Shea S, Padberg GW, Lunt PW, van der Maarel SM (2012) Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: workshop 9th June 2010, LUMC, Leiden, The Netherlands. Neuromuscul Dis NMD 22(5):463–470CrossRef Lemmers RJ, O’Shea S, Padberg GW, Lunt PW, van der Maarel SM (2012) Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: workshop 9th June 2010, LUMC, Leiden, The Netherlands. Neuromuscul Dis NMD 22(5):463–470CrossRef
10.
go back to reference Ricci G, Scionti I, Sera F, Govi M, D’Amico R, Frambolli I et al (2013) Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain J Neurol 136(Pt 11):3408–3417CrossRef Ricci G, Scionti I, Sera F, Govi M, D’Amico R, Frambolli I et al (2013) Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain J Neurol 136(Pt 11):3408–3417CrossRef
11.
go back to reference Lemmers RJ, Goeman JJ, van der Vliet PJ, van Nieuwenhuizen MP, Balog J, Vos-Versteeg M et al (2015) Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Human Mol Genet 24(3):659–669. doi:10.1093/hmg/ddu486 CrossRef Lemmers RJ, Goeman JJ, van der Vliet PJ, van Nieuwenhuizen MP, Balog J, Vos-Versteeg M et al (2015) Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Human Mol Genet 24(3):659–669. doi:10.​1093/​hmg/​ddu486 CrossRef
12.
go back to reference Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M et al (1996) Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy, The FSH-DY Group. Ann Neurol 39(6):744–748CrossRefPubMed Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M et al (1996) Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy, The FSH-DY Group. Ann Neurol 39(6):744–748CrossRefPubMed
13.
go back to reference Butz M, Koch MC, Muller-Felber W, Lemmers RJ, van der Maarel SM, Schreiber H (2003) Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers. J Neurol 250(8):932–937CrossRefPubMed Butz M, Koch MC, Muller-Felber W, Lemmers RJ, van der Maarel SM, Schreiber H (2003) Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers. J Neurol 250(8):932–937CrossRefPubMed
14.
go back to reference Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B et al (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45(6):751–757CrossRefPubMed Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B et al (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45(6):751–757CrossRefPubMed
15.
go back to reference Scionti I, Greco F, Ricci G, Govi M, Arashiro P, Vercelli L et al (2012) Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet 90(4):628–635CrossRefPubMedPubMedCentral Scionti I, Greco F, Ricci G, Govi M, Arashiro P, Vercelli L et al (2012) Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet 90(4):628–635CrossRefPubMedPubMedCentral
17.
go back to reference Kilmer DD, Abresch RT, McCrory MA, Carter GT, Fowler WM Jr, Johnson ER et al (1995) Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil Assoc Acad Physiatr 74(5):S131–S139CrossRef Kilmer DD, Abresch RT, McCrory MA, Carter GT, Fowler WM Jr, Johnson ER et al (1995) Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil Assoc Acad Physiatr 74(5):S131–S139CrossRef
18.
go back to reference Carter GT, Bird TD (2005) Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 64(2):401 (author reply) CrossRefPubMed Carter GT, Bird TD (2005) Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 64(2):401 (author reply) CrossRefPubMed
19.
go back to reference Stubgen JP, Schultz C (2009) Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy. Muscle Nerve 39(6):729–734CrossRefPubMed Stubgen JP, Schultz C (2009) Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy. Muscle Nerve 39(6):729–734CrossRefPubMed
20.
go back to reference D’Angelo MG, Romei M, Lo Mauro A, Marchi E, Gandossini S, Bonato S et al (2011) Respiratory pattern in an adult population of dystrophic patients. J Neurol Sci 306(1–2):54–61CrossRefPubMed D’Angelo MG, Romei M, Lo Mauro A, Marchi E, Gandossini S, Bonato S et al (2011) Respiratory pattern in an adult population of dystrophic patients. J Neurol Sci 306(1–2):54–61CrossRefPubMed
21.
go back to reference Scully MA, Eichinger KJ, Donlin-Smith CM, Tawil R, Statland JM (2014) Restrictive lung involvement in facioscapulohumeral muscular dystrophy. Muscle Nerve 50(5):739–743CrossRefPubMedPubMedCentral Scully MA, Eichinger KJ, Donlin-Smith CM, Tawil R, Statland JM (2014) Restrictive lung involvement in facioscapulohumeral muscular dystrophy. Muscle Nerve 50(5):739–743CrossRefPubMedPubMedCentral
22.
go back to reference Santos DB, Boussaid G, Stojkovic T, Orlikowski D, Letilly N, Behin A et al (2015) Respiratory muscle dysfunction in facioscapulohumeral muscular dystrophy. Neuromuscul Dis NMD 25(8):632–639CrossRef Santos DB, Boussaid G, Stojkovic T, Orlikowski D, Letilly N, Behin A et al (2015) Respiratory muscle dysfunction in facioscapulohumeral muscular dystrophy. Neuromuscul Dis NMD 25(8):632–639CrossRef
23.
go back to reference Trucco Federica, Pedemonte Marina, Fiorillo Chiara, Tacchetti Paola, Brisca Giacomo, Bruno Claudio, Minetti Carlo (2016) Respiratory pattern in a FSHD pediatric population. Respir Med 119:78–80CrossRefPubMed Trucco Federica, Pedemonte Marina, Fiorillo Chiara, Tacchetti Paola, Brisca Giacomo, Bruno Claudio, Minetti Carlo (2016) Respiratory pattern in a FSHD pediatric population. Respir Med 119:78–80CrossRefPubMed
24.
go back to reference Della Marca G, Frusciante R, Dittoni S, Vollono C, Buccarella C, Iannaccone E et al (2009) Sleep disordered breathing in facioscapulohumeral muscular dystrophy. J Neurol Sci 285(1–2):54–58CrossRefPubMed Della Marca G, Frusciante R, Dittoni S, Vollono C, Buccarella C, Iannaccone E et al (2009) Sleep disordered breathing in facioscapulohumeral muscular dystrophy. J Neurol Sci 285(1–2):54–58CrossRefPubMed
25.
go back to reference Rupprecht S, Hagemann G, Witte OW, Schwab M (2009) Alveolar hypoventilation as an early symptom of muscle weakness in facioscapulohumeral muscular dystrophy. Sleep Med 10(5):592–593CrossRefPubMed Rupprecht S, Hagemann G, Witte OW, Schwab M (2009) Alveolar hypoventilation as an early symptom of muscle weakness in facioscapulohumeral muscular dystrophy. Sleep Med 10(5):592–593CrossRefPubMed
26.
go back to reference Brouwer OF, Padberg GW, Wijmenga C, Frants RR (1994) Facioscapulohumeral muscular dystrophy in early childhood. Arch Neurol 51(4):387–394CrossRefPubMed Brouwer OF, Padberg GW, Wijmenga C, Frants RR (1994) Facioscapulohumeral muscular dystrophy in early childhood. Arch Neurol 51(4):387–394CrossRefPubMed
27.
go back to reference Pearson M (2004) National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care—Preface. Thorax 59(Suppl 1):1–232 Pearson M (2004) National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care—Preface. Thorax 59(Suppl 1):1–232
28.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968CrossRefPubMed Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968CrossRefPubMed
Metadata
Title
Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
Authors
Sandra Moreira
Libby Wood
Debbie Smith
Chiara Marini-Bettolo
Michela Guglieri
Grace McMacken
Geraldine Bailey
Anna Mayhew
Robert Muni-Lofra
Gail Eglon
Maggie Williams
Volker Straub
Hanns Lochmüller
Teresinha Evangelista
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 6/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8525-9

Other articles of this Issue 6/2017

Journal of Neurology 6/2017 Go to the issue